Skip to content
TrustList
BC
Investor

Brandon Capital's Medical Research Commercialisation Fund

Life science investment collaboration in Australia and New Zealand, now called Brandon BioCatalyst

Brandon Capital's Medical Research Commercialisation Fund cover

TrustList summary

Brandon Capital's Medical Research Commercialisation Fund, or MRCF, is a life science investment collaboration for Australia and New Zealand. In 2022 it was renamed Brandon BioCatalyst. It is managed by Brandon Capital, a life science venture investor.

What the fund does

  • Early to expansion funding: supports life science companies from proof of concept through to commercialisation.
  • Translation expertise: Brandon Capital guides research discoveries towards commercial products.
  • Co-investment capacity: investors can invest alongside the funds, giving extra room to support portfolio companies.

Customers and markets

The collaboration links more than 50 medical research institutes and hospitals in Australia and New Zealand with superannuation funds and government bodies. Investors and venture partners come from Australia, New Zealand, the United States and the United Kingdom. The aim is to turn promising discoveries into new treatments and better patient outcomes.

Key facts

  • Founded: 2007, in Melbourne
  • Founders: Chris Nave, Stephen Thompson and David Fisher
  • Portfolio: helped form and fund over 50 life science companies
  • Offices: Australia, New Zealand, London and San Francisco

Summary written by TrustList from the business's own published information, Oct 2026.

Categories & features

Brandon Capital's Medical Research Commercialisation Fund rankings

Brandon Capital's Medical Research Commercialisation Fund is ranked on 5 TrustList rankings: #4 on 1, #8 on 1, #12 on 1, #14 on 1 and #25 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Brandon Capital's Medical Research Commercialisation Fund has no reviews yet and 2 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Investor · 5 rankings

  • #4of 17
    United states

    It is the only one of the 17 here listing biotech and science.

    Its profile: “Investors and venture partners come from Australia, New Zealand, the United States and the United Kingdom.”

    Of the 17 here, 6 also cover series and 5 also cover FinTech; 4 also work in Silicon Valley and 4 also work in London.

    Behind Oceanwood Capital Management.

  • #8of 21
    Sydney

    It is the only one of the 21 here listing medical and one of 2 here listing early stage.

    Of the 21 here, 4 also cover series a and 4 also cover partners; 13 also work in New York City and 11 also work in Dubai.

    Behind Ellerston Capital.

  • #12of 52
    Biotech investors

    It is one of 9 here listing partners and one of 14 here listing seed stage.

    Of the 52 here, 14 also cover seed stage and 14 also cover healthtech; 15 also work in Boston and 10 also work in San Francisco.

    Ahead of Lightstone Ventures.

  • #14of 199
    Seed stage

    It is one of 2 here listing medical and one of 3 here listing science.

    Of the top 56 here, 24 also cover pre seed and 11 also cover growth stage; 4 also work in Bangalore.

  • #25of 151
    London

    It is one of 3 here listing medical and one of 4 here listing early stage.

    Of the top 59 here, 8 also cover artificial intelligence; 12 also work in Hong Kong and 10 also work in Toronto.

As of 2026-11-16. Organic ranks only; sponsored placements are never ranks. How TrustList ranks

What the business tells TrustList

Founded
2007 (19 years) evidence sent

Ask TrustList to introduce you to Brandon Capital's Medical Research Commercialisation Fund

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Brandon Capital's Medical Research Commercialisation Fund

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Brandon Capital's Medical Research Commercialisation Fund.

Brandon Capital's Medical Research Commercialisation Fund alternatives

Similar listings buyers compare against this one.

Network of New York City business incubators and accelerators run through NYU Tandon for early-stage ventures

European venture firm funding healthcare and biotechnology companies from creation to expansion

Venture arm of a crypto exchange group investing in early-stage Web3 and crypto start-ups

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Life sciences venture firm working with entrepreneurs to build healthcare and drug-development companies

Early-stage venture investor backing founders of foundational technology, especially data, security and DevOps

Vienna-based venture capital firm investing in early-stage digital health and wellbeing start-ups across Europe and the US